ProShare Advisors LLC - CADENCE PHARMACEUTICALS INC ownership

CADENCE PHARMACEUTICALS INC's ticker is CADX and the CUSIP is 12738T100. A total of 100 filers reported holding CADENCE PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of CADENCE PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2013$383,000
-12.4%
42,358
-38.8%
0.01%
-40.0%
Q3 2013$437,000
+15.6%
69,194
+24.7%
0.01%
+42.9%
Q2 2013$378,00055,4980.01%
Other shareholders
CADENCE PHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
OMNI PARTNERS LLP 250,000$3,500,0005.20%
BlackRock Institutional Trust Company, N.A. 6,178$86,0000.00%
CITIGROUP INC 13,052$183,0000.00%
View complete list of CADENCE PHARMACEUTICALS INC shareholders